MedTrace Logo

The Impact of Robot Assisted Therapy and Metacognitive Skills Training for Children With Hemiparesis

NCT04309266 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2023-12-29

No results posted yet for this study

Summary

The Occupational Therapy Department at Boston Children's Hospital is teaming up with MGH Institute of Health Professions to explore the benefits of using robot assisted therapy (Amadeo) and a problem solving approach (Active Learning Program for Stroke) to achieving functional goals for children ages 7-17 years old that have hemiparesis. The hope is to help participants make gains in both hand/arm skills and progress in everyday activities such as self-care, play, school and work. Participation will look like regular therapy with sessions 3 times weekly for 8 weeks. Each visit will include time for games on the Amadeo and time spent problem solving current activity challenges for each child. Families are encouraged to participate.

Conditions

  • Hemiparesis
  • Hemiplegic Cerebral Palsy
  • Hemiparesis;Poststroke/CVA

Interventions

DEVICE

Amadeo by Tyromotion

Distal upper extremity/hand robot for robot-assisted therapy

BEHAVIORAL

Active Learning Protocol for Stroke

Metacognitive approach involving active problem solving for using the affected upper extremity in motoric activities. Also includes a home program.

Sponsors & Collaborators

Principal Investigators

  • Casey Rabideau, MS, OTR, BCP · Department of Physical and Occupational Therapy Service

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-11
Primary Completion
2023-12-31
Completion
2024-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04309266 on ClinicalTrials.gov